Invention Grant
- Patent Title: Modified alginates for cell encapsulation and cell therapy
-
Application No.: US17080355Application Date: 2020-10-26
-
Publication No.: US11337930B2Publication Date: 2022-05-24
- Inventor: Arturo J. Vegas , Minglin Ma , Kaitlin M. Bratlie , Daniel G. Anderson , Robert S. Langer
- Applicant: Massachusetts Institute of Technology , The Children's Medical Center Corporation
- Applicant Address: US MA Cambridge; US MA Boston
- Assignee: Massachusetts Institute of Technology,The Children's Medical Center Corporation
- Current Assignee: Massachusetts Institute of Technology,The Children's Medical Center Corporation
- Current Assignee Address: US MA Cambridge; US MA Boston
- Agency: Pabst Patent Group LLP
- Main IPC: A61K9/50
- IPC: A61K9/50 ; A61K9/00 ; C08B37/00 ; A61K35/39 ; A61K45/06 ; A61K9/51
Abstract:
Covalently modified alginate polymers, possessing enhanced biocompatibility and tailored physiochemical properties, as well as methods of making and use thereof, are disclosed herein. The covalently modified alginates are useful as a matrix for the encapsulation and transplantation of cells. Also disclosed are high throughput methods for the characterizing the biocompatibility and physiochemical properties of modified alginate polymers.
Public/Granted literature
- US20210186886A1 MODIFIED ALGINATES FOR CELL ENCAPSULATION AND CELL THERAPY Public/Granted day:2021-06-24
Information query
